Eric Baudin mainly focuses on Internal medicine, Endocrinology, Thyroid carcinoma, Pathology and Thyroid. The study incorporates disciplines such as Gastroenterology, Surgery and Oncology in addition to Internal medicine. His Surgery research is multidisciplinary, relying on both Octreotide and Carcinoid syndrome.
His work on Thyroid cancer and Medullary carcinoma as part of his general Endocrinology study is frequently connected to Context, thereby bridging the divide between different branches of science. As a part of the same scientific family, Eric Baudin mostly works in the field of Pathology, focusing on Metastasis and, on occasion, Treatment modality. His research in Thyroid intersects with topics in Radiation therapy, Neck dissection and Lymph node.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Oncology, Neuroendocrine tumors and Pathology. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery. Eric Baudin combines subjects such as Cancer and Chromogranin A with his study of Endocrinology.
His Oncology research includes elements of Prospective cohort study, Chemotherapy, Paraganglioma and Endocrine system. Eric Baudin works mostly in the field of Neuroendocrine tumors, limiting it down to topics relating to Metastasis and, in certain cases, Radiology. His Thyroid carcinoma research integrates issues from Medullary cavity, Carcinoma and Lymph node.
Internal medicine, Oncology, Neuroendocrine tumors, Paraganglioma and Gastroenterology are his primary areas of study. His Internal medicine study frequently draws parallels with other fields, such as Endocrinology. His study in Oncology is interdisciplinary in nature, drawing from both Etoposide, Adrenocortical carcinoma, Adjuvant therapy and Endocrine system.
The concepts of his Neuroendocrine tumors study are interwoven with issues in Cancer stem cell, Radionuclide therapy, Pancreas, Primary tumor and Diagnosis management. His Paraganglioma research also works with subjects such as
His scientific interests lie mostly in Internal medicine, Oncology, Neuroendocrine tumors, Paraganglioma and Retrospective cohort study. The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways. His Oncology study integrates concerns from other disciplines, such as Tumour classification, Atypical carcinoid, Clinical trial and Ectopic ACTH syndrome.
His study explores the link between Neuroendocrine tumors and topics such as Endocrine system that cross with problems in Lymph node and Clinical endpoint. Eric Baudin interconnects Germline, Mutation rate, Prospective cohort study, DNA sequencing and Genetic testing in the investigation of issues within Paraganglioma. His research integrates issues of Mutation, Survival rate, Thyroidectomy, Natural history and Multiple endocrine neoplasia type 2b in his study of Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma : benefits and limits of radioiodine therapy
C. Durante;N. Haddy;E. Baudin;S. Leboulleux.
The Journal of Clinical Endocrinology and Metabolism (2006)
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Samuel A. Wells;Bruce G. Robinson;Robert F. Gagel;Henning Dralle.
Journal of Clinical Oncology (2012)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E Pavel;John D Hainsworth;Eric Baudin;Marc Peeters.
The Lancet (2011)
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
Marianne Pavel;Eric Baudin;Anne Couvelard;Eric Krenning.
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Laurence Amar;Jérôme Bertherat;Eric Baudin;Christiane Ajzenberg.
Journal of Clinical Oncology (2005)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin.
The New England Journal of Medicine (2012)
Prognostic Factors for Persistent or Recurrent Disease of Papillary Thyroid Carcinoma with Neck Lymph Node Metastases and/or Tumor Extension beyond the Thyroid Capsule at Initial Diagnosis
Sophie Leboulleux;Carole Rubino;Eric Baudin;Bernard Caillou.
The Journal of Clinical Endocrinology and Metabolism (2005)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Martyn E. Caplin;E. Baudin;P. Ferolla;P. Filosso.
Annals of Oncology (2015)
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.
Barbara Pasini;Sarah R. McWhinney;Thalia Bei;Ludmila Matyakhina.
European Journal of Human Genetics (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: